The Juvenescence business model and future of anti-agingAuthor: Phil Newman | Published on: April 30, 2020 | Last updated: May 10, 2022 Greg BaileyCEO, JuvenescenceThe Juvenescence business model and future of anti-aging Share this article: Editor's choiceEmpowering cells to boost energy and recovery is a winning moveStudy disproves benefits of probiotics for vaginal healthHow do Tour De France athletes recover so fast? Performance coach reveals the secret9 proven ways to beat brain fog and enhance your energyLongevity investment platform opens-up to international investorsUrolithin A research opens door to osteoarthritis relief Popular articlesLongevity is ‘Pivotal’ to accelerating social progressEyeing up a non-invasive, inexpensive method to track human agingLongevity investment bulletin: Turn Bio, Celularity, MyndYou and more.Telomere shortening linked to signs of Alzheimer’s, research showsUK MHRA to streamline clinical trial approvals in significant overhaul of trial regulationShining a light on cardiovascular aging
